{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T22:07:59Z","timestamp":1761862079785,"version":"build-2065373602"},"reference-count":129,"publisher":"Wiley","issue":"7","license":[{"start":{"date-parts":[[2009,2,18]],"date-time":"2009-02-18T00:00:00Z","timestamp":1234915200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Diabetes Obesity Metabolism"],"published-print":{"date-parts":[[2009,7]]},"abstract":"<jats:p>Obesity is considered as a major health problem, as its prevalence continuously rises worldwide. One of the common health consequences of obesity is type 2 diabetes mellitus. Therefore, antiobesity management is a prerequisite in treating diabetic patients. Lifestyle modifications combined with pharmacological agents appear to be an effective approach. Sibutramine is a serotonin\u2013noradrenaline reuptake inhibitor, which acts centrally by promoting the feeling of satiety and decreasing caloric intake, thus resulting in weight loss. A potential association with cardiovascular side effects has been noted. Orlistat, a gastric and pancreatic lipase inhibitor, also achieves significant weight loss and improves glycaemic status, but it has gastrointestinal side effects. Rimonabant, the first endocannabinoid CB1 antagonist, is associated with weight reduction and it improves diabetic parameters; nevertheless, it is associated with psychiatric disorders; indeed, a recently conducted safety review led to the temporal suspension of its commercialization. The above\u2010mentioned medications seem to be currently useful agents for treating obesity in patients with type 2 diabetes mellitus. Other medications used for diabetes management, such as exenatide, liraglutide and pramlintide, have also shown body weight reduction. Ongoing research is needed to scrutinize the precise impact of these agents in the daily clinical practice of management of obesity in patients with type 2 diabetes mellitus.<\/jats:p>","DOI":"10.1111\/j.1463-1326.2008.01026.x","type":"journal-article","created":{"date-parts":[[2009,2,19]],"date-time":"2009-02-19T00:06:09Z","timestamp":1235001969000},"page":"641-664","source":"Crossref","is-referenced-by-count":8,"title":["Effect of antiobesity medications in patients with type 2 diabetes mellitus"],"prefix":"10.1111","volume":"11","author":[{"given":"Souzana","family":"Choussein","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Angeliki A.","family":"Makri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Constantinos C.","family":"Frangos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eleni Th.","family":"Petridou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stella S.","family":"Daskalopoulou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2009,5,28]]},"reference":[{"issue":"2","key":"e_1_2_5_2_2","first-page":"51S","article-title":"Clinical guidelines on the identification, evaluation, and treatment of overweight and obesity in adults \u2013 the evidence report. National Institutes of Health","volume":"6","year":"1998","journal-title":"Obes Res"},{"key":"e_1_2_5_3_2","unstructured":"World Health Organization Public Health Agency of Canada.Public Health Agency of Canada. Preventing Chronic Diseases: A Vital Investment. Geneva:World Health Organization; Public Health Agency of Canada 2005. Available online:http:\/\/www.who.int\/chp\/chronic%5Fdisease%5Freport\/contents\/en\/index.htm."},{"key":"e_1_2_5_4_2","doi-asserted-by":"publisher","DOI":"10.1093\/epirev\/mxm012"},{"key":"e_1_2_5_5_2","first-page":"252","volume-title":"Kumar and Clark Clinical Medicine","author":"Kumar PJ","year":"2005"},{"key":"e_1_2_5_6_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(07)60033-6"},{"key":"e_1_2_5_7_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ahj.2005.03.006"},{"key":"e_1_2_5_8_2","first-page":"437","article-title":"New antiobesity agents in type 2 diabetes: overview of clinical trials with sibutramine and orlistat","volume":"28","author":"Scheen AJ","year":"2002","journal-title":"Diabetes Metab"},{"key":"e_1_2_5_9_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa012512"},{"key":"e_1_2_5_10_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM200105033441801"},{"key":"e_1_2_5_11_2","doi-asserted-by":"publisher","DOI":"10.1093\/ajcn\/68.4.899"},{"key":"e_1_2_5_12_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199309303291401"},{"key":"e_1_2_5_13_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-051X.1988.tb01003.x"},{"key":"e_1_2_5_14_2","doi-asserted-by":"publisher","DOI":"10.2337\/diaspect.20.3.159"},{"key":"e_1_2_5_15_2","first-page":"299","article-title":"Anti\u2010obesity. Current management of obesity","volume":"37","author":"Cheah JS","year":"1996","journal-title":"Singapore Med J"},{"key":"e_1_2_5_16_2","doi-asserted-by":"publisher","DOI":"10.1001\/archinte.1984.00350180055008"},{"key":"e_1_2_5_17_2","doi-asserted-by":"publisher","DOI":"10.1093\/ajcn\/55.1.199s"},{"key":"e_1_2_5_18_2","doi-asserted-by":"publisher","DOI":"10.1385\/ENDO:29:1:49"},{"key":"e_1_2_5_19_2","doi-asserted-by":"publisher","DOI":"10.1185\/03007997309111712"},{"key":"e_1_2_5_20_2","doi-asserted-by":"publisher","DOI":"10.1038\/oby.2004.151"},{"key":"e_1_2_5_21_2","first-page":"129","article-title":"Fluoxetine: a randomized clinical trial in the treatment of obesity","volume":"18","author":"Goldstein DJ","year":"1994","journal-title":"Int J Obes Relat Metab Disord"},{"key":"e_1_2_5_22_2","first-page":"487","article-title":"Effectiveness of phenylpropanolamine in the management of moderate obesity","volume":"16","author":"Schteingart DE","year":"1992","journal-title":"Int J Obes Relat Metab Disord"},{"key":"e_1_2_5_23_2","first-page":"48","article-title":"Scientific and legal issues in fenfluramine\/dexfenfluramine litigation","volume":"96","author":"Poston WS","year":"2000","journal-title":"Tex Med"},{"key":"e_1_2_5_24_2","article-title":"Long\u2010term pharmacotherapy for obesity and overweight","author":"Padwal R","year":"2003","journal-title":"Cochrane Database Syst Rev"},{"key":"e_1_2_5_25_2","first-page":"538","article-title":"Comparison of the effects of sibutramine and orlistat on obese, poorly\u2010controlled type 2 diabetic patients","volume":"30","author":"Chou KM","year":"2007","journal-title":"Chang Gung Med J"},{"key":"e_1_2_5_26_2","first-page":"222","article-title":"Comparison of metabolic effects of orlistat and sibutramine treatment in type 2 diabetic obese patients","volume":"17","author":"Derosa G","year":"2004","journal-title":"Diabetes Nutr Metab"},{"key":"e_1_2_5_27_2","doi-asserted-by":"publisher","DOI":"10.2337\/diacare.24.11.1957"},{"key":"e_1_2_5_28_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1464-5491.2005.01569.x"},{"key":"e_1_2_5_29_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1368-5031.2005.00568.x"},{"key":"e_1_2_5_30_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1463-1326.2000.00071.x"},{"key":"e_1_2_5_31_2","doi-asserted-by":"publisher","DOI":"10.2337\/diacare.26.1.125"},{"key":"e_1_2_5_32_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1464-5491.2002.00655.x"},{"key":"e_1_2_5_33_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1463-1326.2000.00081.x"},{"key":"e_1_2_5_34_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.clinthera.2004.09.017"},{"key":"e_1_2_5_35_2","doi-asserted-by":"publisher","DOI":"10.1038\/sj.ijo.0802591"},{"key":"e_1_2_5_36_2","doi-asserted-by":"publisher","DOI":"10.2337\/dc06-1120"},{"key":"e_1_2_5_37_2","doi-asserted-by":"publisher","DOI":"10.1185\/030079905X38132"},{"key":"e_1_2_5_38_2","doi-asserted-by":"publisher","DOI":"10.1358\/dot.2004.40.1.799437"},{"key":"e_1_2_5_39_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jnutbio.2007.05.007"},{"key":"e_1_2_5_40_2","doi-asserted-by":"publisher","DOI":"10.1017\/S1368980007000717"},{"key":"e_1_2_5_41_2","doi-asserted-by":"publisher","DOI":"10.1038\/sj.jhh.1001299"},{"key":"e_1_2_5_42_2","doi-asserted-by":"publisher","DOI":"10.1038\/sj.ijo.0802887"},{"key":"e_1_2_5_43_2","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehm217"},{"key":"e_1_2_5_44_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.0000036370.31856.73"},{"key":"e_1_2_5_45_2","doi-asserted-by":"publisher","DOI":"10.1055\/s-2002-22671"},{"key":"e_1_2_5_46_2","article-title":"Blood pressure changes associated with sibutramine and weight management \u2013 an analysis from the 6\u2010week lead\u2010in period of the sibutramine cardiovascular outcomes trial (SCOUT)","author":"Sharma AM","year":"2008","journal-title":"Diabetes Obes Metab"},{"key":"e_1_2_5_47_2","doi-asserted-by":"publisher","DOI":"10.2165\/00003495-199856020-00007"},{"key":"e_1_2_5_48_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1463-1326.2005.00483.x"},{"key":"e_1_2_5_49_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1464-5491.2004.01474.x"},{"key":"e_1_2_5_50_2","doi-asserted-by":"publisher","DOI":"10.2165\/00003495-200161140-00011"},{"key":"e_1_2_5_51_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1463-1326.2003.00262.x"},{"key":"e_1_2_5_52_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1462-8902.2004.00359.x"},{"key":"e_1_2_5_53_2","doi-asserted-by":"publisher","DOI":"10.2337\/diacare.26.6.1667"},{"key":"e_1_2_5_54_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1463-1326.2002.00237.x"},{"key":"e_1_2_5_55_2","doi-asserted-by":"publisher","DOI":"10.2337\/diacare.25.6.1033"},{"key":"e_1_2_5_56_2","doi-asserted-by":"publisher","DOI":"10.2337\/diacare.27.1.33"},{"key":"e_1_2_5_57_2","doi-asserted-by":"publisher","DOI":"10.1001\/archinte.160.9.1321"},{"key":"e_1_2_5_58_2","doi-asserted-by":"publisher","DOI":"10.2337\/dc06-0210"},{"key":"e_1_2_5_59_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1464-5491.2002.00823.x"},{"key":"e_1_2_5_60_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2796.2000.00720.x"},{"key":"e_1_2_5_61_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1463-1326.2004.00467.x"},{"key":"e_1_2_5_62_2","doi-asserted-by":"publisher","DOI":"10.2337\/diacare.21.8.1288"},{"key":"e_1_2_5_63_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1742-1241.2006.01052.x"},{"key":"e_1_2_5_64_2","doi-asserted-by":"publisher","DOI":"10.2337\/diacare.25.7.1123"},{"key":"e_1_2_5_65_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1464-5491.2005.01723.x"},{"key":"e_1_2_5_66_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF00280883"},{"key":"e_1_2_5_67_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.281.3.235"},{"key":"e_1_2_5_68_2","doi-asserted-by":"publisher","DOI":"10.1001\/archfami.9.2.160"},{"key":"e_1_2_5_69_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(97)11509-4"},{"key":"e_1_2_5_70_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0014-2999(02)01422-X"},{"key":"e_1_2_5_71_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1463-1326.2003.00264.x"},{"key":"e_1_2_5_72_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1742-1241.2006.01210.x"},{"key":"e_1_2_5_73_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00125-007-0890-y"},{"key":"e_1_2_5_74_2","doi-asserted-by":"publisher","DOI":"10.1038\/nrd1495"},{"key":"e_1_2_5_75_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa044537"},{"key":"e_1_2_5_76_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00125-008-1048-2"},{"key":"e_1_2_5_77_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(06)69571-8"},{"key":"e_1_2_5_78_2","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2007.03.053"},{"key":"e_1_2_5_79_2","doi-asserted-by":"publisher","DOI":"10.2337\/dc08-0386"},{"key":"e_1_2_5_80_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2826.2008.01681.x"},{"key":"e_1_2_5_81_2","unstructured":"Clinical trials.gov.Search of: diabetes obesity\u2010list results.2008. Available from URL:http:\/\/clinicaltrials.gov\/ct2\/results?term=rimonabant+diabetes. Accessed September 2008."},{"issue":"1","key":"e_1_2_5_82_2","article-title":"Rimonabant improves glycemic control in insulin\u2010treated type 2 diabetes: the ARPEGGIO trial (Abstract)","volume":"57","author":"Hollander P","year":"2008","journal-title":"Diabetes"},{"key":"e_1_2_5_83_2","unstructured":"BhattD.Rimonabant improves glycemic control in insulin\u2010treated type 2 diabetes (ARPEGGIO).2008. Available from URL:http:\/\/www.cardiosource.com\/clinicaltrials\/trial.asp?trialID=1713. Accessed September 2008."},{"key":"e_1_2_5_84_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjmed.2006.11.014"},{"key":"e_1_2_5_85_2","doi-asserted-by":"publisher","DOI":"10.2337\/dc08-0386"},{"key":"e_1_2_5_86_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.beem.2007.08.005"},{"key":"e_1_2_5_87_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.diabet.2007.02.001"},{"key":"e_1_2_5_88_2","doi-asserted-by":"publisher","DOI":"10.2174\/138920309787315149"},{"key":"e_1_2_5_89_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2005.12.067"},{"key":"e_1_2_5_90_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(05)66374-X"},{"key":"e_1_2_5_91_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.295.7.761"},{"key":"e_1_2_5_92_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.299.13.1547"},{"key":"e_1_2_5_93_2","doi-asserted-by":"publisher","DOI":"10.4158\/EP.13.7.790"},{"key":"e_1_2_5_94_2","doi-asserted-by":"publisher","DOI":"10.2337\/dc08-s258"},{"key":"e_1_2_5_95_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(07)61721-8"},{"key":"e_1_2_5_96_2","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehn076"},{"key":"e_1_2_5_97_2","unstructured":"EMEA.The European Medicines Agency recommends suspension of the marketing authorisation of Acomplia (press release). Avaliable from URL:http:\/\/www.emea.europa.eu\/humandocs\/PDFs\/EPAR\/acomplia\/53777708en.pdf. Accessed September 2008."},{"key":"e_1_2_5_98_2","doi-asserted-by":"publisher","DOI":"10.2337\/diacare.28.6.1311"},{"key":"e_1_2_5_99_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00592-004-0158-7"},{"key":"e_1_2_5_100_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1463-1326.2008.00921.x"},{"key":"e_1_2_5_101_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.pharmthera.2008.02.003"},{"key":"e_1_2_5_102_2","doi-asserted-by":"publisher","DOI":"10.1007\/s11883-008-0009-z"},{"key":"e_1_2_5_103_2","doi-asserted-by":"publisher","DOI":"10.2337\/diacare.29.02.06.dc05-1267"},{"key":"e_1_2_5_104_2","doi-asserted-by":"publisher","DOI":"10.2337\/diacare.28.5.1092"},{"key":"e_1_2_5_105_2","doi-asserted-by":"publisher","DOI":"10.2337\/diacare.27.11.2628"},{"key":"e_1_2_5_106_2","doi-asserted-by":"publisher","DOI":"10.2337\/diacare.28.5.1083"},{"key":"e_1_2_5_107_2","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-143-8-200510180-00006"},{"key":"e_1_2_5_108_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.clinthera.2007.11.006"},{"key":"e_1_2_5_109_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00125-006-0510-2"},{"key":"e_1_2_5_110_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1463-1326.2006.00589.x"},{"key":"e_1_2_5_111_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1463-1326.2006.00602.x"},{"key":"e_1_2_5_112_2","doi-asserted-by":"publisher","DOI":"10.2337\/dc06-2375"},{"key":"e_1_2_5_113_2","doi-asserted-by":"publisher","DOI":"10.1007\/s12519-008-0002-1"},{"key":"e_1_2_5_114_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(06)69705-5"},{"key":"e_1_2_5_115_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(08)61206-4"},{"key":"e_1_2_5_116_2","doi-asserted-by":"publisher","DOI":"10.2337\/diacare.27.6.1335"},{"key":"e_1_2_5_117_2","first-page":"363","article-title":"Managed care perspective on three new agents for type 2 diabetes","volume":"14","author":"VanDeKoppel S","year":"2008","journal-title":"J Manag Care Pharm"},{"key":"e_1_2_5_118_2","doi-asserted-by":"publisher","DOI":"10.1124\/pr.59.2.2"},{"key":"e_1_2_5_119_2","doi-asserted-by":"publisher","DOI":"10.1038\/oby.2004.76"},{"key":"e_1_2_5_120_2","doi-asserted-by":"publisher","DOI":"10.1089\/15209150252924094"},{"key":"e_1_2_5_121_2","doi-asserted-by":"publisher","DOI":"10.1038\/sj.ijo.0803446"},{"key":"e_1_2_5_122_2","first-page":"414","article-title":"Cetilistat, a new lipase inhibitor for the treatment of obesity","volume":"9","author":"Padwal R","year":"2008","journal-title":"Curr Opin Investig Drugs"},{"key":"e_1_2_5_123_2","unstructured":"Alizyme\u2010Cetilistat:.2008; Available from URL:http:\/\/www.alizyme.com\/alizyme\/products\/cetilistat\/. Accessed September 2008."},{"key":"e_1_2_5_124_2","doi-asserted-by":"publisher","DOI":"10.2337\/diacare.27.1.155"},{"journal-title":"Cochrane Database Syst Rev","article-title":"Pharmacotherapy for weight loss in adults with type 2 diabetes mellitus","author":"Norris SL","key":"e_1_2_5_125_2"},{"key":"e_1_2_5_126_2","doi-asserted-by":"publisher","DOI":"10.1001\/archinte.164.13.1395"},{"key":"e_1_2_5_127_2","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.39385.413113.25"},{"key":"e_1_2_5_128_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(08)61207-6"},{"key":"e_1_2_5_129_2","doi-asserted-by":"publisher","DOI":"10.1038\/sj.ijo.0801889"},{"key":"e_1_2_5_130_2","doi-asserted-by":"publisher","DOI":"10.1037\/0022-006X.53.1.111"}],"container-title":["Diabetes, Obesity and Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1463-1326.2008.01026.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/dom-pubs.pericles-prod.literatumonline.com\/doi\/pdf\/10.1111\/j.1463-1326.2008.01026.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T22:01:42Z","timestamp":1761861702000},"score":1,"resource":{"primary":{"URL":"https:\/\/dom-pubs.pericles-prod.literatumonline.com\/doi\/10.1111\/j.1463-1326.2008.01026.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,5,28]]},"references-count":129,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2009,7]]}},"alternative-id":["10.1111\/j.1463-1326.2008.01026.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1463-1326.2008.01026.x","archive":["Portico"],"relation":{},"ISSN":["1462-8902","1463-1326"],"issn-type":[{"type":"print","value":"1462-8902"},{"type":"electronic","value":"1463-1326"}],"subject":[],"published":{"date-parts":[[2009,5,28]]}}}